Latest Litigation News

News Corporation has settled longstanding legal disputes involving the Murdoch Family Trust, restructuring beneficiary holdings and consolidating voting control under Lachlan Murdoch.

Orica Limited reports robust earnings growth across all segments for FY2025, underpinned by successful gas supply deals, digital expansion, and progress in hydrogen funding despite ongoing litigation costs.

Noumi Limited has completed its $11.56 million payment towards a $43 million class action settlement, now unconditional following Victorian Supreme Court approval. The payment was made by insurers, activating legal releases for the company.

PT Aneka Tambang Tbk (ANTAM) posted a 7% increase in sales to Rp23.19 trillion in the first half of 2024, driven by strong domestic gold sales, and reported a net profit of Rp1.51 trillion. The company also completed significant divestments, retaining control of SDA while divesting majority ownership in FHT.

Bathurst Resources reports a dip in FY25 earnings due to lower coal prices and operational challenges but pushes forward with key development projects Buller and Tenas, targeting production growth from FY29.

Mayne Pharma reported a 5% revenue increase to $408.1 million for FY25 but posted a net loss of $93.8 million, narrowing from the prior year. The company’s planned acquisition by Cosette Pharmaceuticals faces legal hurdles, delaying completion.

Next Science Limited reported a 7% revenue decline and a 20% reduction in net loss for H1 2025, alongside a major $50 million asset sale agreement with OSARTIS GmbH. The transaction, approved by shareholders, signals a strategic pivot for the biofilm-focused medical device company.

Jatcorp Limited reported a $6.9 million net loss for FY25, hit by a trademark dispute in China that suspended key product sales. Despite setbacks, the company is accelerating new channel growth and product innovation to regain momentum.

humm Group Limited reported a remarkable 458% increase in net profit for FY25, driven by strong asset growth and effective cost management. The company also announced a final dividend and highlighted ongoing technology transformation and ESG commitments.

Shine Justice Ltd reported a revenue increase to $204.4 million in FY25 despite a dip in adjusted net profit after tax, driven by strategic restructuring and a sharpened focus on personal injury and international mass torts. The company is investing in technology and expanding its US footprint to fuel growth in FY26.

Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.

Atlas Arteria reported a 32.9% drop in statutory net profit for H1 2025 due to a new French tax, yet achieved solid toll revenue and EBITDA growth, maintaining its 2025 distribution guidance.